Pharmaceutical

Gilead and Tentarix partner on cancer and inflammation therapies

Gilead Sciences has entered into partnerships with Tentarix for the development of new therapies for oncology and inflammatory diseases.

Aug 16, 2023 - 20:00
Gilead and Tentarix partner on cancer and inflammation therapies
Gilead Sciences has entered into partnerships with Tentarix for the development of new therapies for oncology and inflammatory diseases.
Read the original article

Tags:

Previous Article

Leprosy potentially endemic in Central Florida

Next Article

Patient Death Causes 2seventy Bio’s CD33-Targeted CAR-T Cell Therapy Trial to be...

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: STAT-Harris Poll: Nearly half of U.S. adults would spend $100 a month for Ozempic, other weight loss drugs

STAT+: STAT-Harris Poll: Nearly half of U.S. adults wou...

Jun 26, 2023

We wish we’d written that: STAT staffers share their favorite stories of 2023

We wish we’d written that: STAT staffers share their fa...

Dec 29, 2023

Kellogg’s is going to war over Mexico’s nutrition label rules. A similar fight is coming to the U.S.

Kellogg’s is going to war over Mexico’s nutrition label...

Aug 21, 2023